Position in PAHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$436,727
+$141,733 QoQ
Shares Held
7,896
0.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PDT Partners, LLC holds $16,723,036 across 8 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
117,378 | $4,816,019 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
45,442 | $3,761,688 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
132,368 | $3,358,176 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
40,567 | $2,594,259 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
25,858 | $1,202,655 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
14,891 | $539,054 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
24,489 | $244,890 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
41,845 | $206,295 |
All Filings in PAHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $436,727 | 7,896 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $294,994 | 7,896 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $380,162 | 9,396 | Shares | Sole | 2025-11-17 | |
| 2022-06-30 | $210,085 | 10,982 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $303,240 | 15,200 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $310,384 | 15,200 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $398,037 | 18,479 | Shares | Sole | 2021-11-15 | |
| 2020-03-31 | $604,250 | 25,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||